Evolução da função pulmonar após tratamento com goserelina em pacientes com linfangioleiomiomatose Evolution of pulmonary function after treatment with goserelin in patients with lymphangioleiomyomatosis

Evolução da função pulmonar após tratamento com goserelina em pacientes com linfangioleiomiomatose Evolution of pulmonary function after treatment with goserelin in patients with lymphangioleiomyomatosis

Nas células musculares lisas atípicas características da linfangioleiomiomatose (LAM) encontram-se receptores de estrogênio e progesterona, de modo que o tratamento anti-hormonal pode ser considerado uma opção, mas ainda com resultados controversos. O objetivo deste trabalho foi avaliar retrospectiv...

Full description

Bibliographic Details
Main Authors:	Bruno Guedes Baldi, Pedro Medeiros Junior, Suzana Pinheiro Pimenta, Roberto Iglesias Lopes, Ronaldo Adib Kairalla, Carlos Roberto Ribeiro Carvalho
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Pneumologia e Tisiologia 2011-06-01
Series:	Jornal Brasileiro de Pneumologia
Subjects:	Linfangioleiomiomatose Espirometria Gosserrelina Lymphangioleiomyomatosis Spirometry Goserelin
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132011000300015

Similar Items

Linfangioleiomiomatose pulmonar Pulmonary Lymphangioleiomyomatosis
by: Pedro Medeiros Junior, et al.
Published: (2004-02-01)

Doxiciclina em pacientes com linfangioleiomiomatose: segurança e eficácia no bloqueio de metaloproteinases Doxycycline use in patients with lymphangioleiomyomatosis: safety and efficacy in metalloproteinase blockade
by: Suzana Pinheiro Pimenta, et al.
Published: (2011-08-01)

Linfangioleiomiomatose - A propósito de três casos clínicos Lymphangioleiomyomatosis - report of three cases
by: Carla Valente, et al.
Published: (2010-01-01)

Doxiciclina em pacientes com linfangioleiomiomatose: biomarcadores e resposta funcional pulmonar Doxycycline use in patients with lymphangioleiomyomatosis: biomarkers and pulmonary function response
by: Suzana Pinheiro Pimenta, et al.
Published: (2013-02-01)

Esclerose tuberosa com envolvimento pulmonar Tuberous sclerosis with pulmonary involvment
by: Susana Ferreira, et al.
Published: (2010-04-01)

Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations
by: Carolina Salim Gonçalves Freitas, et al.
Published: (2015-06-01)

Pulmonary lymphangioleiomyomatosis (PLAM)
by: Verma S, et al.
Published: (2007-01-01)

Função respiratória em filhos de mães asmáticas Respiratory function in children of asthmatic mothers
by: Marco A. Valadares, et al.
Published: (2013-04-01)

Efficacy and safety of goserelin combined with adjuvant chemotherapy in premenopausal women with breast cancer
by: Yang Wang, et al.
Published: (2015-11-01)

Anestesia para cesariana em paciente com linfangioleiomiomatos
by: Andresa Cavalcante Rodrigues, et al.
Published: (2018-04-01)

Advances in the Diagnosis, Treatment and Prognosis of Lymphangioleiomyomatosis
by: CHENG Chongsheng, et al.
Published: (2022-01-01)

Advances in imaging study of pulmonary lymphangioleiomyomatosis
by: LIKE Lahu, YANG Wenjie
Published: (2022-12-01)

Identification of predictors based on drug targets highlights accurate treatment of goserelin in breast and prostate cancer
by: Yue Zhao, et al.
Published: (2021-01-01)

Immunohistological features related to functional impairment in lymphangioleiomyomatosis
by: Ellen Caroline Toledo do Nascimento, et al.
Published: (2018-05-01)

Comparação entre provas de função pulmonar, escore de Shwachman-Kulczycki e escore de Brasfield em pacientes com fibrose cística Comparison among pulmonary function test results, the Shwachman-Kulczycki score and the Brasfield score in patients with cystic fibrosis
by: Ivanice Duarte Freire, et al.
Published: (2008-05-01)

Development of identification test methods for triptorelin acetate and goserelin acetate substances using NMR spectroscopy
by: S. V Moiseev, et al.
Published: (2019-03-01)

Physiotherapy in lymphangioleiomyomatosis: a systematic review
by: Victoria Maria Garcia de Medeiros, et al.
Published: (2022-12-01)

An entity that poses continuous challenge despite treatment attempt: lymphangioleiomyomatosis
by: Munish Sharma, et al.
Published: (2020-10-01)

Efeito da obesidade na função ventilatória Impact of obesity on ventilatory function
by: Perran Boran, et al.
Published: (2007-04-01)

A rare case of lymphangioleiomyomatosis with recurrent pneumothorax
by: Vinay Mahishale, et al.
Published: (2015-01-01)

Effects of sirolimus on Lung function in patients with Lymphangioleiomyomatosis
by: Fatemeh Aghaeimeybodi, et al.
Published: (2019-01-01)

Effectiveness of pulmonary rehabilitation in lymphangioleiomyomatosis
by: Manivel Arumugam, et al.
Published: (2021-01-01)

ADJUVANT GOSERELIN IN PRE-MENOPAUSAL PATIENTS WITH EARLY BREAST CANCER: RESULTS FROM THE ZIPP STUDY
by: M. Baum, et al.
Published: (2014-09-01)

The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trial
by: Leonard R, et al.
Published: (2020-08-01)

Pulmonary lymphangioleiomyomatosis presenting as spontaneous pneumothorax treated with sirolimus - A case report
by: Ajay Kumar Verma, et al.
Published: (2018-01-01)

A Clinicopathological Analysis of Pulmonary Lymphangioleiomyomatosis
by: Jun GAO, et al.
Published: (2011-04-01)

Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis
by: Contini Paola, et al.
Published: (2011-10-01)

Intraoperative mechanical ventilation and incidence of pneumothorax in lymphangioleiomyomatosis
by: Chen Sun, et al.
Published: (2024-03-01)

Sporadic Lymphangioleiomyomatosis Disease: A Case Report
by: Yousef Nikmanesh, et al.
Published: (2023-09-01)

Chronic pelvic pain due to pelvic lymphangioleiomyomatosis: A case report
by: Tetsu Wakimoto, et al.
Published: (2016-05-01)

Goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnover
by: Caroline Wilson, et al.
Published: (2016-03-01)

Pneumothorax as a Presentation of Tuberous Sclerosis-Associated Lymphangioleiomyomatosis
by: Duarte Lages Silva, et al.
Published: (2019-09-01)

Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method
by: Carolina S. G. Freitas, et al.
Published: (2017-04-01)

Lymphangioleiomyomatosis: Searching for potential biomarkers
by: Eva Revilla-López, et al.
Published: (2023-02-01)

Malignant presentation of uterine lymphangioleiomyomatosis
by: Dariusz Szpurek, et al.
Published: (2015-10-01)

Pulmonary lymphangioleiomyomatosis (case report)
by: Shashina M.M., et al.
Published: (2017-12-01)

YouTube-videos for patient education in lymphangioleiomyomatosis?
by: Finn M. Wilkens, et al.
Published: (2022-04-01)

Possible Novel Therapeutic Targets in Lymphangioleiomyomatosis Treatment
by: Xixi Song, et al.
Published: (2020-09-01)

Lymphangioleiomyomatosis of the lungs: features of the clinical picture, diagnosis and treatment. Case report
by: Galina L. Ignatova, et al.
Published: (2022-05-01)

Pregnancy after the diagnosis of lymphangioleiomyomatosis (LAM)
by: Lisha Shen, et al.
Published: (2021-03-01)